Moreover, the profile of renal PGE2 receptor (EP1–EP 4) expression was altered in STZ diabetic mice [11] and EP1-selective antagonist strikingly retarded the progression of nephropathy as shown by significant improvement of mesangial expansion, glomerular hypertrophy and proteinuria [12]. The gene discussed is PTGER1; the disease is kidney disorder.